Abstract 2014: SHP2 stabilizes EGFR and beta-catenin to promote the transformation and tumorigenic potential of basal-like and triple-negative breast cancer cells
2019 ◽
Keyword(s):
Keyword(s):
2021 ◽
Vol 34
◽
pp. 102383
Keyword(s):